China · Delayed Price · Currency is CNY Jiangsu Nanfang Medical Statistics
Total Valuation
SHA:603880 has a market cap or net worth of CNY 1.97 billion. The enterprise value is 2.36 billion.
| Market Cap | 1.97B |
| Enterprise Value | 2.36B |
Important Dates
The next confirmed earnings date is Monday, August 31, 2026.
| Earnings Date | Aug 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:603880 has 289.04 million shares outstanding. The number of shares has decreased by -0.52% in one year.
| Current Share Class | 289.04M |
| Shares Outstanding | 289.04M |
| Shares Change (YoY) | -0.52% |
| Shares Change (QoQ) | -3.42% |
| Owned by Insiders (%) | 52.42% |
| Owned by Institutions (%) | 4.71% |
| Float | 137.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.38 |
| PB Ratio | 11.20 |
| P/TBV Ratio | 14.99 |
| P/FCF Ratio | 38.96 |
| P/OCF Ratio | 35.13 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.03 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 46.51 |
Financial Position
The company has a current ratio of 0.48, with a Debt / Equity ratio of 2.52.
| Current Ratio | 0.48 |
| Quick Ratio | 0.30 |
| Debt / Equity | 2.52 |
| Debt / EBITDA | n/a |
| Debt / FCF | 8.76 |
| Interest Coverage | -3.52 |
Financial Efficiency
Return on equity (ROE) is -43.32% and return on invested capital (ROIC) is -13.58%.
| Return on Equity (ROE) | -43.32% |
| Return on Assets (ROA) | -4.97% |
| Return on Invested Capital (ROIC) | -13.58% |
| Return on Capital Employed (ROCE) | -30.69% |
| Weighted Average Cost of Capital (WACC) | 5.64% |
| Revenue Per Employee | 741,039 |
| Profits Per Employee | -125,327 |
| Employee Count | 789 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 3.97 |
Taxes
In the past 12 months, SHA:603880 has paid 7.63 million in taxes.
| Income Tax | 7.63M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.70% in the last 52 weeks. The beta is 0.32, so SHA:603880's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | +10.70% |
| 50-Day Moving Average | 7.81 |
| 200-Day Moving Average | 6.87 |
| Relative Strength Index (RSI) | 41.00 |
| Average Volume (20 Days) | 13,892,742 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603880 had revenue of CNY 584.68 million and -98.88 million in losses. Loss per share was -0.34.
| Revenue | 584.68M |
| Gross Profit | 13.72M |
| Operating Income | -77.50M |
| Pretax Income | -90.56M |
| Net Income | -98.88M |
| EBITDA | n/a |
| EBIT | -77.50M |
| Loss Per Share | -0.34 |
Balance Sheet
The company has 65.48 million in cash and 443.85 million in debt, with a net cash position of -378.37 million or -1.31 per share.
| Cash & Cash Equivalents | 65.48M |
| Total Debt | 443.85M |
| Net Cash | -378.37M |
| Net Cash Per Share | -1.31 |
| Equity (Book Value) | 176.20M |
| Book Value Per Share | 0.60 |
| Working Capital | -343.42M |
Cash Flow
In the last 12 months, operating cash flow was 56.19 million and capital expenditures -5.52 million, giving a free cash flow of 50.67 million.
| Operating Cash Flow | 56.19M |
| Capital Expenditures | -5.52M |
| Depreciation & Amortization | n/a |
| Net Borrowing | -32.17M |
| Free Cash Flow | 50.67M |
| FCF Per Share | 0.18 |
Margins
Gross margin is 2.35%, with operating and profit margins of -13.26% and -16.91%.
| Gross Margin | 2.35% |
| Operating Margin | -13.26% |
| Pretax Margin | -15.49% |
| Profit Margin | -16.91% |
| EBITDA Margin | n/a |
| EBIT Margin | -13.26% |
| FCF Margin | 8.67% |
Dividends & Yields
SHA:603880 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.52% |
| Shareholder Yield | 0.52% |
| Earnings Yield | -5.01% |
| FCF Yield | 2.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 21, 2021. It was a forward split with a ratio of 1.3.
| Last Split Date | May 21, 2021 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
SHA:603880 has an Altman Z-Score of 1.04 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.04 |
| Piotroski F-Score | 4 |